Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated VRTX
€ 394.50 0.19%

Geschäftsbericht 2025
hinzugefügt 13.02.2026

report update icon

Vertex Pharmaceuticals Incorporated Abschreibung & Amortisation 2011-2026 | VRTX

Abschreibung & Amortisation Jährlich Vertex Pharmaceuticals Incorporated

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
210 M 207 M 181 M 148 M 126 M 110 M 107 M 72.4 M 61.4 M 61.4 M 62.3 M 63.3 M 48.4 M 38.2 M 35 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
210 M 35 M 102 M

Abschreibung & Amortisation Vierteljährlich Vertex Pharmaceuticals Incorporated

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
54 M 51.7 M 48.4 M - 53.2 M 54 M 53.5 M - - - 38.8 M - 110 M - 35.9 M - 91.8 M - 28.8 M - 80.2 M 53.5 M 26.8 M - 80.7 M 54.8 M 27.1 M - 53.6 M 34.4 M 16.3 M - 45 M 29.7 M 14.8 M - 45.9 M 31.4 M 16.4 M - 46.6 M 30.4 M 16.4 M - 46.9 M 30 M 15.8 M - 30.7 M 21.2 M 10.7 M - 25.8 M 17.2 M 8.56 M - 25.3 M 17.6 M 8.86 M

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
110 M 8.56 M 38.6 M

Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler

Name Abschreibung & Amortisation Preis % 24h Marktkapitalisierung Land
Heron Therapeutics Heron Therapeutics
HRTX
2.31 M $ 0.79 1.9 % $ 132 M usaUSA
Altimmune Altimmune
ALT
112 K $ 3.44 2.99 % $ 303 M usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
27 K - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
131 K - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
31.7 M - -24.86 % $ 820 K usaUSA
Albireo Pharma Albireo Pharma
ALBO
274 K - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
63 K - 10.36 % $ 9.8 M usaUSA
Acasti Pharma Acasti Pharma
ACST
7 K - 4.01 % $ 150 M canadaCanada
Incyte Corporation Incyte Corporation
INCY
93.3 M $ 90.43 -0.21 % $ 17.7 B usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
2.62 M $ 1.54 -2.41 % $ 34.1 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.65 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
66 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
162 K - - $ 7.46 M israelIsrael
Cullinan Management Cullinan Management
CGEM
311 K $ 13.57 7.1 % $ 818 M usaUSA
Atreca Atreca
BCEL
5.46 M - -11.76 % $ 5.79 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
140 K - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
142 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Calithera Biosciences Calithera Biosciences
CALA
300 K - -10.95 % $ 876 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
259 K - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.14 M - - $ 3.74 B usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
941 K $ 16.82 -1.06 % $ 835 M britainBritain
Clovis Oncology Clovis Oncology
CLVS
8.5 M - -7.23 % $ 13 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
461 K $ 2.13 1.67 % $ 199 M israelIsrael
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
340 K $ 7.11 -6.82 % $ 866 K usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
7.8 M $ 20.99 4.07 % $ 3.45 B usaUSA
Keros Therapeutics Keros Therapeutics
KROS
1.51 M $ 11.16 1.82 % $ 415 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
1.4 M $ 4.35 2.48 % $ 722 M canadaCanada
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
6 K - -5.98 % $ 34.1 M usaUSA